Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients

被引：0
|
作者：
M Wilbaux
E Hénin
A Oza
O Colomban
E Pujade-Lauraine
G Freyer
M Tod
B You
机构：
[1] EMR 3738,Department of Medical Oncology and Hematology
[2] Ciblage Thérapeutique en Oncologie,undefined
[3] Faculté de Médecine et de Maïeutique Lyon-Sud Charles Mérieux,undefined
[4] Université Claude Bernard Lyon 1,undefined
[5] Princess Margaret Hospital,undefined
[6] University Health Network,undefined
[7] Hôpital Hôtel Dieu,undefined
[8] Place du Parvis Notre-Dame,undefined
[9] Service d’Oncologie Médicale,undefined
[10] Investigational Center for Treatments in Oncology and Hematology of Lyon,undefined
[11] Centre Hospitalier Lyon-Sud,undefined
[12] Hospices Civils de Lyon,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
CA-125 kinetics; ovarian epithelial cancer; mathematical modelling; K–PD modelling; tumour size prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1517 / 1524
页数：7
相关论文
共 50 条
  • [1] Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients
    Wilbaux, M.
    Henin, E.
    Oza, A.
    Colomban, O.
    Pujade-Lauraine, E.
    Freyer, G.
    Tod, M.
    You, B.
    BRITISH JOURNAL OF CANCER, 2014, 110 (06) : 1517 - 1524
  • [2] Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy
    Sabbatini, P.
    Mooney, D.
    Iasonos, A.
    Thaler, H.
    Aghajanian, C.
    Hensley, M.
    Konner, J.
    Spriggs, D.
    Abu-Rustum, N. R.
    Dupont, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) : 589 - 594
  • [3] CA-125 IN MONITORING CHEMOTHERAPY OF PATIENTS WITH OVARIAN-CANCER - EARLY RESPONSE TO THE TREATMENT
    MARKOWSKA, J
    KOPCZYNSKI, Z
    MANYS, G
    SZEWIERSKI, Z
    NEOPLASMA, 1990, 37 (06) : 687 - 692
  • [4] CA-125 as response criterion in patients with epithelial ovarian cancer
    Zirpel, I
    Illiger, HJ
    STRAHLENTHERAPIE UND ONKOLOGIE, 2000, 176 (04) : 200 - 200
  • [5] CA-125 IN THE MONITORING OF RESPONSE TO CHEMOTHERAPY OF OVARIAN-CARCINOMA
    QUARANTA, M
    LORUSSO, V
    COVIELLO, M
    MICELLI, G
    CASAMASSIMA, A
    INTERNATIONAL JOURNAL OF CANCER, 1988, : 68 - 70
  • [6] Normalization of CA-125 levels in patients with ovarian cancer undergoing intraperitoneal chemotherapy
    McBee, W. C.
    Richard, S. D.
    Seamon, L. G.
    Lesnock, J.
    O'Malley, D. M.
    Richardson, D. L.
    Krivak, T. C.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S144 - S144
  • [7] CA-125 Response Patterns in Patients With Recurrent Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (PLD)
    Oaknin, Ana
    Barretina, Pilar
    Perez, Xavier
    Jimenez, Laura
    Velasco, Montserrat
    Alsina, Maria
    Brunet, Joan
    Ramon Germa, Josep
    Beltran, Miguel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (01) : 87 - 91
  • [8] Omentin as an adjunct to CA-125 in detecting recurrent ovarian cancer
    Lewis, Kelsey
    Yeung, Chi Lam Au
    Mok, Samuel
    Lu, Karen
    CANCER RESEARCH, 2017, 77
  • [9] CA-125 criteria for response evaluation in ovarian cancer
    Sundar, S
    O'byrne, KJ
    GYNECOLOGIC ONCOLOGY, 2005, 98 (03) : 520 - 521
  • [10] Preoperative prediction of optimal resectability in advanced ovarian cancer using CA-125
    Berek, JS
    GYNECOLOGIC ONCOLOGY, 2000, 77 (02) : 225 - 226
12345